GERM-LINE P53 MUTATION IS UNCOMMON IN PATIENTS WITH TRIPLE PRIMARY CANCERS

被引：24

作者：

SHISEKI, M

NISHIKAWA, R

YAMAMOTO, H

OCHIAI, A

SUGIMURA, H

SHITARA, N

SAMESHIMA, Y

MIZOGUCHI, H

SUGIMURA, T

YOKOTA, J

机构：

[1] NATL CANC CTR, RES INST, DIV BIOL, 1-1 TSUKIJI 5 CHOME, CHUO KU, TOKYO 104, JAPAN

[2] TOKYO WOMENS MED COLL, DEPT HEMATOL, SHINJUKU KU, TOKYO 162, JAPAN

[3] NATL CANC CTR, CHUO KU, TOKYO 104, JAPAN

[4] NATL CANC CTR, RES INST, DIV PATHOL, CHUO KU, TOKYO 104, JAPAN

[5] HAMAMATSU UNIV SCH MED, HAMAMATSU, SHIZUOKA 43131, JAPAN

[6] KOMAGOME METROPOLITAN HOSP, BUNKYO KU, TOKYO 113, JAPAN

来源：

CANCER LETTERS | 1993年 / 73卷 / 01期

关键词：

LI-FRAUMENI SYNDROME; GERM-LINE P53 MUTATION; MULTIPLE PRIMARY CANCERS; TUMOR SUPPRESSOR GENE;

D O I：

10.1016/0304-3835(93)90187-E

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We examined five patients with multiple primary cancers who had a history of three different types of primary cancers for germ-line p53 mutations. The germ-line p53 mutation was detected in a patient who conformed to the Li-Fraumeni syndrome, but not in the other four patients. The diagnosis of these four patients did not fall in the category of Li-Fraumeni syndrome. This result indicates that germ-line p53 mutations are uncommon even in patients with triple primary cancers.

引用

页码：51 / 57

页数：7

共 50 条

[1] A novel germ-line mutation in p53 gene
Roesler, Wojciech
Przybyla, Anna
Mackiewicz, Andrzej
Lamperska, Katarzyna
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2006, 10 (01): : 21 - 23
[2] Incidence of germ-line p53 mutations in patients with gliomas
Li, YJ
Sanson, M
HoangXuan, K
Delattre, JY
Poisson, M
Thomas, G
Hamelin, R
INTERNATIONAL JOURNAL OF CANCER, 1995, 64 (06) : 383 - 387
[3] IDENTIFICATION OF A GERM-LINE MUTATION IN THE P53 GENE IN A PATIENT WITH AN INTRACRANIAL EPENDYMOMA
METZGER, AK
SHEFFIELD, VC
DUYK, G
DANESHVAR, L
EDWARDS, MSB
COGEN, PH
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (17) : 7825 - 7829
[4] Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers
Nichols, KE
Malkin, D
Garber, JE
Fraumeni, JF
Li, FP
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2001, 10 (02) : 83 - 87
[5] GENOMIC STABILITY AND WILD-TYPE P53 FUNCTION OF LYMPHOBLASTOID-CELLS WITH GERM-LINE P53 MUTATION
LALLE, P
MOYRETLALLE, C
WANG, Q
VIALLE, JM
NAVARRO, C
BRESSACDEPAILLERETS, B
MAGAUD, JP
OZTURK, M
ONCOGENE, 1995, 10 (12) : 2447 - 2454
[6] ABSENCE OF P53 GERM-LINE MUTATIONS IN BILATERAL BREAST-CANCER PATIENTS
LIDEREAU, R
SOUSSI, T
HUMAN GENETICS, 1992, 89 (02) : 250 - 252
[7] ABSENCE OF SIGNIFICANT GERM-LINE P53 MUTATIONS IN OVARIAN-CANCER PATIENTS
BULLER, RE
SKILLING, JS
KALISZEWSKI, S
NIEMANN, T
ANDERSON, B
GYNECOLOGIC ONCOLOGY, 1995, 58 (03) : 368 - 374
[8] A novel germ-line mutation in the noncoding region of the p53 gene in a Li-Fraumeni family
Barel, D
Avigad, S
Mor, C
Fogel, M
Cohen, IJ
Zaizov, R
CANCER GENETICS AND CYTOGENETICS, 1998, 103 (01) : 1 - 6
[9] GERM-LINE MUTATIONS OF THE P53 TUMOR SUPPRESSOR GENE IN PATIENTS WITH HIGH-RISK FOR CANCER INACTIVATE THE P53 PROTEIN
FREBOURG, T
KASSEL, J
LAM, KT
GRYKA, MA
BARBIER, N
ANDERSEN, TI
BORRESEN, AL
FRIEND, SH
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (14) : 6413 - 6417
[10] Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer
Lehman, TA
Haffty, BG
Carbone, CJ
Bishop, LR
Gumbs, AA
Krishnan, S
Shields, PG
Modali, R
Turner, BC
CANCER RESEARCH, 2000, 60 (04) : 1062 - 1069

← 1 2 3 4 5 →